TITLE

Lack of effect of inhaled morphine on exercise-induced breathlessness in chronic obstructive pulmonary disease

AUTHOR(S)
Masood, A R; Reed, J W; Thomas, S H
PUB. DATE
June 1995
SOURCE
Thorax;Jun1995, Vol. 50 Issue 6, p629
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
66080698

 

Related Articles

  • Physiological measurement of breathlessness and breathing.  // Thorax;Dec2013 Supplement, Vol. 68 Issue S3, pA60 

    The article presents abstracts on breathlessness and breathing's physiological measurement including neutrophil mediated tissue damage effect in lungs, breathlessness impact in chronic obstructive pulmonary disease (COPD) with cognitive processing, and research on obstructive sleep apnea patients.

  • Inhaled corticosteroids and COPD exacerbations. Kuritzky, Louis // Internal Medicine Alert;3/29/2010, Vol. 32 Issue 6, p48 

    The article reports on the effectiveness of inhaled corticosteroids (ICS) in treating acute exacerbations of chronic obstructive pulmonary disease (AC-COPD).

  • Which Inhaler Combination is Best for COPD Treatment? Elliott, William T. // Internal Medicine Alert;4/15/2007, Vol. 29 Issue 7, p1 

    The article reports on studies which examined the effects of various inhaler combinations on the treatment of chronic obstructive pulmonary disease (COPD).

  • Single inhaler triple therapy effective in patients with COPD.  // British Journal of Hospital Medicine (17508460);Oct2016, Vol. 77 Issue 10, p558 

    The article discusses the findings of a study about the effectiveness of single inhaler triple therapy for the treatment of patients with chronic obstructive pulmonary disease.

  • Safety of Inhaled Anticholinergics for COPD Scrutinized.  // Internal Medicine Alert;10/29/2008 Pharmacology Watch, Vol. 30, p1 

    The article discusses the medical study which investigates the effects of inhaled anticholinergics by patients with chronic obstructive pulmonary disease (COPD).

  • Characteristics of episodic breathlessness as reported by patients with advanced chronic obstructive pulmonary disease and lung cancer: Results of a descriptive cohort study. Weingärtner, Vera; Scheve, Christine; Gerdes, Verena; Schwarz-Eywill, Michael; Prenzel, Regina; Otremba, Burkhard; Mühlenbrock, Juliane; Bausewein, Claudia; Higginson, Irene J; Voltz, Raymond; Herich, Lena; Simon, Steffen T // Palliative Medicine;May2015, Vol. 29 Issue 5, p420 

    The article focuses on a study which aims to describe the characteristics of episodic breathlessness in patients with advanced chronic obstructive pulmonary disease or lung cancer. It says that episodic breathlessness is a form of refractory breathlessness and that better understanding of the...

  • Case Discussion in Palliative Medicine. von Gunten, Charles F. // Journal of Palliative Medicine;Spring2000, Vol. 3 Issue 1, p93 

    Presents the case of a 75-year-old man with advanced chronic obstructive pulmonary disease and tracheal stenosis. Treatment of the patient; Details of the morphine infusion conducted on the man; Issues illustrated by the case; Side effects of morphine.

  • INDACATEROL: A NEW APPROVED MOLECULE TO TREAT COPD. Jaithlia, Rajiv; Suresh Dev, Kr.; Gupta, Akash; Tanwar, Ravindra; Chouhan, Chetan // International Journal of Research in Ayurveda & Pharmacy;Sep2012, Vol. 3 Issue 5, p1518 

    Indacaterol approved as once-daily bronchodilator for chronic obstructive pulmonary disease (COPD). Indacaterol is a new molecular entity in the �2-adrenergic agonist class taken only once a day unlike the currently available �2-adrenergic agonist that helps relax muscles around lung...

  • INDACATEROL: A NEW APPROVED MOLECULE TO TREAT COPD. Jaithlia, Rajiv; Dev, Suresh Kr.; Gupta, Akash; Tanwar, Ravindra; Chouhan, Chetan // International Journal of Research in Ayurveda & Pharmacy;Sep2011, Vol. 2 Issue 5, p1518 

    Indacaterol approved as once-daily bronchodilator for chronic obstructive pulmonary disease (COPD). Indacaterol is a new molecular entity in the β2-adrenergic agonist class taken only once a day unlike the currently available β2-adrenergic agonist that helps relax muscles around lung...

  • INHALER THERAPY FOR OBSTRUCTIVE AIRWAY DISEASE.  // Journal of the Nepal Medical Association;Jul/Aug2004, Vol. 43 Issue 154, p1 

    Presents information on the effectiveness of inhaler therapy for chronic obstructive pulmonary disease (COPD). Varieties of inhalers for the treatment of COPD; Benefits of metered dose inhaler (MDI); Precautions in using MDI.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics